Pharmaceutical Technology-09-02-2013

Pharmaceutical Technology

The Importance of Continued Investment in R&D

September 02, 2013

Guest Editorial

37

9

There has been a notable shift in interest for life-science companies over recent months from institutional investors investing through the public markets, but any plans to release further capital will rely on first-rate R&D.

Quality by Design in APIs

September 02, 2013

Cover Story

37

9

The adoption of quality by design in small-molecule drug development and manufacturing continues to evolve as the industry seeks ways to augment process understanding for APIs

Effective and Efficient Weighing of Potent Compounds

September 02, 2013

Peer-Reviewed Research

37

9

The advantages of using an automated powder dispensing system in a ventilated balance enclosure for efficient handling and effective containment of potent compounds are discussed.

XstalBio Introduces CentuRecon

September 02, 2013

Product Spotlight

37

9

CentuRecon enables dry formulations of therapeutic proteins to quickly be prepared for injection at high concentration.

Multivariate Approaches for Powder Characterization

September 02, 2013

Ask the Expert

37

9

John Yin, an applications specialist with Freeman Technology, discusses the importance of powder-characterization techniques for optimizing pharmaceutical product development and manufacturing processes.

Advancing Chiral Chemistry in Pharmaceutical Synthesis

September 02, 2013

API Synthesis & Manufacturing

37

9

Developments involve stereoretentive cross-coupling, enantioselective alcohol silylation, strategies for amplifying signals in circular dichroism spectroscopy, and a synthetic route for the natural product ingenol.

Pharmaceutical Technology, September 2013 Issue (PDF)

September 02, 2013

Issue PDF

37

9

Click the title above to open the Pharmaceutical Technology September 2013 issue in an interactive PDF format.